Bruce is a trial lawyer who concentrates his practice on antitrust litigation and other complex commercial litigation matters. He has successfully defended a large chemical company in a criminal antitrust price fixing investigation brought by the U.S. Department of Justice, Antitrust Division and the U.S. Postal Service, Office of Inspector General; after a lengthy investigation, the government closed the matter with no enforcement action recommended.
Bruce also has successfully defended a major global health care device and supply company in a $1 billion antitrust suit; he defended the largest health care group purchasing organization (GPO) in a $600 million antitrust suit. Bruce was a key member of the trial team that prevented Hexion Specialty Chemicals from terminating its $6.5 billion agreement to acquire his client’s company; after trial, the case settled when Hexion and its majority owner paid the client $1 billion.
Bruce has also defended ERISA cases involving putative class action claims and represented companies in connection with breach of contract, tortious interference, and patent infringement claims arising out of domestic and international transactions. He also regularly provides antitrust counseling and guidance to health care providers, major pharmaceutical companies, and joint ventures involving competitor collaborations.